183 related articles for article (PubMed ID: 18193916)
21. Selective serotonin reuptake inhibitors' passage into human milk of lactating women.
Pogliani L; Baldelli S; Cattaneo D; Pileri P; Clementi E; Cetin I; Zuccotti G
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3020-3025. PubMed ID: 29557689
[No Abstract] [Full Text] [Related]
22. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.
Skinner MH; Kuan HY; Pan A; Sathirakul K; Knadler MP; Gonzales CR; Yeo KP; Reddy S; Lim M; Ayan-Oshodi M; Wise SD
Clin Pharmacol Ther; 2003 Mar; 73(3):170-7. PubMed ID: 12621382
[TBL] [Abstract][Full Text] [Related]
23. Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization-tandem mass spectrometry and its application to pharmacokinetic study.
Senthamil Selvan P; Gowda KV; Mandal U; Sam Solomon WD; Pal TK
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):269-75. PubMed ID: 17904920
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ; McCormack PL
CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects.
Suri A; Reddy S; Gonzales C; Knadler MP; Branch RA; Skinner MH
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):78-84. PubMed ID: 15726876
[TBL] [Abstract][Full Text] [Related]
27. Sertraline and desmethylsertraline in human breast milk and nursing infants.
Stowe ZN; Owens MJ; Landry JC; Kilts CD; Ely T; Llewellyn A; Nemeroff CB
Am J Psychiatry; 1997 Sep; 154(9):1255-60. PubMed ID: 9286185
[TBL] [Abstract][Full Text] [Related]
28. Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women.
Korth-Bradley JM; Parks V; Chalon S; Gourley I; Matschke K; Gossart S; Bryson P; Fleckenstein L
Antimicrob Agents Chemother; 2011 Nov; 55(11):5200-4. PubMed ID: 21896908
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorder.
Lobo ED; Quinlan T; Prakash A
Clin Pharmacokinet; 2014 Aug; 53(8):731-40. PubMed ID: 24989060
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
[TBL] [Abstract][Full Text] [Related]
31. Duloxetine: clinical pharmacokinetics and drug interactions.
Knadler MP; Lobo E; Chappell J; Bergstrom R
Clin Pharmacokinet; 2011 May; 50(5):281-94. PubMed ID: 21366359
[TBL] [Abstract][Full Text] [Related]
32. The safety of duloxetine during pregnancy and lactation.
Andrade C
J Clin Psychiatry; 2014 Dec; 75(12):e1423-7. PubMed ID: 25551238
[TBL] [Abstract][Full Text] [Related]
33. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects.
Lantz RJ; Gillespie TA; Rash TJ; Kuo F; Skinner M; Kuan HY; Knadler MP
Drug Metab Dispos; 2003 Sep; 31(9):1142-50. PubMed ID: 12920170
[TBL] [Abstract][Full Text] [Related]
34. Psychotropic medications in lactation.
Llewellyn A; Stowe ZN
J Clin Psychiatry; 1998; 59 Suppl 2():41-52. PubMed ID: 9559759
[TBL] [Abstract][Full Text] [Related]
35. Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety.
Hurley DJ; Turner CL; Yalcin I; Viktrup L; Baygani SK
Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):120-8. PubMed ID: 16188367
[TBL] [Abstract][Full Text] [Related]
36. A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers.
Melka D; Kask K; Colli E; Regidor PA
Womens Health (Lond); 2020; 16():1745506520957192. PubMed ID: 32903172
[TBL] [Abstract][Full Text] [Related]
37. Effects of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady state in healthy subjects.
Chappell J; He J; Knadler MP; Mitchell M; Lee D; Lobo E
J Clin Pharmacol; 2009 Dec; 49(12):1456-66. PubMed ID: 19793910
[TBL] [Abstract][Full Text] [Related]
38. Excretion of paroxetine into breast milk.
Ohman R; Hägg S; Carleborg L; Spigset O
J Clin Psychiatry; 1999 Aug; 60(8):519-23. PubMed ID: 10485633
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study.
Solaro C; Bergamaschi R; Rezzani C; Mueller M; Trabucco E; Bargiggia V; Dematteis F; Mattioda A; Cimino V; Restivo D; Patti F; Cavalla P
Clin Neuropharmacol; 2013; 36(4):114-6. PubMed ID: 23783007
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
